September 5th 2025
Many states are enacting restrictions on insurers’ prior authorization policies, but these laws may increase costs and lead to other undesirable consequences.
Cost-Sharing and Initiation of Disease-Modifying Therapy for Multiple Sclerosis
This study examines the association between cost-sharing and initiation of disease-modifying therapies among privately insured patients with multiple sclerosis.
Read More
Which Components of Health Information Technology Will Drive Financial Value?
This framework suggests new meaningful use measures and guidance for prioritizing implementation of different health information technology functionalities, based on their expected financial effects.
Read More
Patient Medical Group Continuity and Healthcare Utilization
Patients who often change medical groups have the highest healthcare costs. The improved coordination of an accountable care organization may reduce those costs.
Read More
The Challenges in Manufacturing Biologics [Video]
August 22nd 2012This content is brought to you by Amgen This video summarizes the complex process of creating biologics from start to finish and describes some of the unique challenges-- and tremendous effort-- involved in delivering safe and effective biologics.
Read More
Measuring Migraine-Related Quality of Care Across 10 Health Plans
Standardized measurement of migraine, an underdiagnosed and perhaps underrecognized condition, is necessary for health plans to understand utilization of costly diagnostic and treatment services.
Read More